SAB Biotherapeutics (SABS) Return on Sales Growth (1y) (2022 - 2024)
SAB Biotherapeutics (SABS) Return on Sales Growth (1y) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.11 Bn | 1,785.05 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.57 Bn | 468.78 Bn | 1.35 Bn | 0.00 |
| 4 | Vertex Pharmaceuticals | 123.78 Bn | 116.54 Bn | 2.59 Bn | 0.00 |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.98 Bn | 3.31 Bn | 0.00 |
| 6 | Belite Bio | 62.12 Bn | 62.12 Bn | - | - |
| 7 | Argenx Se | 54.64 Bn | 49.45 Bn | 1.41 Bn | 0.00 |
| 8 | Alnylam Pharmaceuticals | 38.05 Bn | 35.05 Bn | 959.66 Mn | 0.00 |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - | - |
| 10 | SAB Biotherapeutics | 185.58 Mn | 185.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -12.00 |
| Sep 30, 2024 | -26.00 |
| Jun 30, 2024 | 53.00 |
| Mar 31, 2024 | 7.00 |
| Dec 31, 2023 | -71.00 |
| Sep 30, 2023 | -2.00 |
| Jun 30, 2023 | -80.00 |
| Mar 31, 2023 | -13.00 |
| Dec 31, 2022 | -3.00 |
| Sep 30, 2022 | -2.00 |
| Jun 30, 2022 | -1.00 |
| Mar 31, 2022 | 0.00 |